Phthalazine derivatives for treating inflammatory diseases
AssigneeNovartis AG
InventorsGuido Bold, Janet King, Jorg Frei, Richard Heng, Paul Manley, Bernhard Wietfeld, Jeanette Wood
Life of this patent
Estimating the term…
Loading patent…
AssigneeNovartis AG
InventorsGuido Bold, Janet King, Jorg Frei, Richard Heng, Paul Manley, Bernhard Wietfeld, Jeanette Wood
Estimating the term…
The invention relates to the treatment of leukemias with an inhibitor of the activity of VEGF receptor tyrosine kinase of the formula I, the substituents being defined in the specification; as well as to new phthalazine derivatives; processes for the preparation thereof; the application thereof in a process for the treatment of the human or animal body; the use thereof for the treatment of a disease, especially a disease caused by ocular neovascularization, such as age-related macula degeneration or diabetic retinopathy, or other diseases that respond to the inhibition of tyrosine kinases, such as a proliferative disease; a method for the treatment of such disease in mammals; and the use of such a compound for the manufacture of a pharmaceutical preparation for the treatment especially of a disease as mentioned above.
1-32. (canceled)
A method of treating leukemias comprising administering a compound of formula I,
Dependencies are inferred from the claim text.